Visit COVID-19 resources

[Skip to Content]

Age-related macular degeneration

New Guidance for Commissioning Age Related Macular Degeneration Services

The Royal College of Ophthalmologists (RCOphth) has developed Age Related Macular Degeneration Commissioning Guidance June 2021. The National Institute for Health and Care Excellence (NICE) has  accredited the process used by The Royal College of Ophthalmologists to develop this guidance. It sets out the  principles and minimum standards of care for AMD to decrease variations

National Ophthalmology Database Funding boost for new UK AMD Audit

The Royal College of Ophthalmologists (RCOphth) is delighted to announce that the National Ophthalmology Database (NOD) Audit: Age-Related Macular Degeneration has now received funding for three years, enabling this important programme of long-term research and data gathering to begin. Age-related macular degeneration (AMD) remains a leading cause of sight impairment despite new treatment options. It

Age Related Macular degeneration (AMD) Services: Commissioning Guidance Consultation

Please note: This consultation has now closed.  This consultation seeks views on the proposed Age Related Macular degeneration (AMD) Services: Commissioning Guidance. A guidance development group was set up to develop principles and minimum standards of care for AMD to decrease variations of care across AMD services in England and Wales. It also addresses the